Sep 10, 2026 08:30AM
Sep 8, 2026 07:19AM
Aug 6, 2026 06:45AM
Aug 6, 2026 06:45AM
Apr 30, 2026 06:30AM
Apr 21, 2026 08:37AM
Apr 21, 2026 06:45AM Merck and Eisai trial for kidney cancer combination therapy fails endpoints
Apr 21, 2026 06:45AM
Apr 20, 2026 06:48AM
Apr 20, 2026 06:48AM
Apr 13, 2026 07:01AM
Apr 13, 2026 07:00AM
Mar 2, 2026 06:26AM
Feb 28, 2026 10:05AM KEYTRUDA Plus WELIREG Shows 28% Reduction in Cancer Recurrence Risk
Feb 28, 2026 10:05AM
Feb 28, 2026 10:00AM
Feb 25, 2026 12:37PM
Feb 25, 2026 12:37PM
Feb 3, 2026 06:30AM
Nov 19, 2025 06:45AM
Nov 19, 2025 06:45AM Merck Announces Positive Topline Results from the Pivotal Phase 3 Trial Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) in Treatment-Na
Oct 23, 2025 06:00AM
Oct 23, 2025 06:00AM
Oct 18, 2025 10:35AM
Oct 15, 2025 06:45AM
Oct 15, 2025 06:45AM
Sep 19, 2025 06:45AM
Sep 19, 2025 06:45AM Merck Receives Two Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab), for Subcutaneous (SC) Administration and for New Indication for Earlier-Stage Head and Neck Cancer
Jul 29, 2025 06:30AM
Jul 10, 2025 06:45AM
Jul 10, 2025 06:45AM
Jul 2, 2025 06:45AM
Jul 2, 2025 06:45AM
Jun 13, 2025 11:43AM
Apr 27, 2025 12:00PM KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally
Apr 24, 2025 06:30AM
Mar 27, 2025 11:01AM
Mar 27, 2025 11:01AM
Feb 25, 2025 06:45AM
Feb 25, 2025 06:45AM
Feb 4, 2025 06:30AM
Jan 27, 2025 06:45AM FDA Grants Priority Review to Merck’s Application for WELIREG® (belzutifan) for the Treatment of Patients With Advanced Pheochromocytoma and Paraganglioma (PPGL)
Dec 17, 2024 06:46AM
Dec 17, 2024 06:45AM
Dec 11, 2024 09:44AM
Jul 30, 2024 06:30AM
May 29, 2024 07:17AM
May 29, 2024 07:15AM
May 9, 2024 06:46AM Merck (MRK) Provides Update on Phase 3 KEYNOTE-B21 Trial of KEYTRUDA Plus Chemotherapy, With or Without Radiotherapy, for Patients With Newly Diagnosed, High-Risk Endometrial Cancer After Surgery With
May 9, 2024 06:45AM

15,819 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All